Position Summary
The University of Kentucky College of Medicine (UK HealthCare) is seeking a board certified/eligible neurologist with additional expertise in neuromuscular medicine and/or clinical neurophysiologist to join the highly-regarded Department of Neurology. Qualified candidates will have advanced training and expertise in neuromuscular medicine/clinical neurophysiology, in addition to being able to care for the broad spectrum of neurological disorders. Leadership opportunities exist for well-qualified candidates. Candidates with interest in resident and fellow education are encouraged to apply. The incoming neurologist will be based at in the UK Department of Neurology, a principal component of the Kentucky Neuroscience Institute, with inpatient facilities in the flagship UK Albert B. Chandler Hospital, a state-of-the-art facility in which UK HealthCare recently invested $532 million for a 1.2 million sq. ft. addition which effectively doubled hospital bed count.

Neuromuscular Program
The Neuromuscular Disorders Clinic specializes in the evaluation and the newest treatment of the entire spectrum of neuromuscular disorders. The program deals with the diagnosis and treatment of nerve, plexus and spinal root injuries and their complications. We also treat injuries or illnesses of the peripheral autonomic nervous systems, such as familial dysautonomia. Founded in 1989, the UK Botulinum Toxin (Botox) Treatment Clinic is the state's oldest and largest botulinum treatment clinic.

The ALS Multidisciplinary Clinic
The ALS Multidisciplinary Clinic was established in January 2003. It is the only ALS center in Kentucky certified by the ALS Association and focuses on the care of the ALS patient. The clinic utilizes a multidisciplinary team of health care professionals from the ALS Association and UK HealthCare. Edward Kasarskis, MD, PhD, a neurologist specializing in the care of ALS patients, directs the clinic and its operations. The goal of the clinic is to provide optimal patient care, support and quality of life.

Department Overview
UK Neurology, led by Dr. Larry Goldstein, boasts some of the leading clinical and research centers in the country for cerebrovascular disease, epilepsy and Alzheimer’s disease, including a Joint Commission certified Comprehensive Stroke Center, Level 4 NAEC Comprehensive Epilepsy Center, and NIA-designated Alzheimer’s Disease Research Center (ADRC) that has become an international referral center and research powerhouse. The Department of Neurology offers ACGME-accredited adult and child neurology residency program and three post-residency neurology fellowships. The nationally recognized UK Department of Neurology is comprised of a team of more than 30 neurologists and other providers dedicated to patient care, research, and education, and is actively expanding. The UK Department of Neurology is a principal component the Kentucky Neuroscience Institute with inpatient services provided at the UK Chandler Hospital, one of the fast growing academic medical centers in the country. Additionally, The UK Comprehensive Stroke Center and Norton Healthcare joined with area hospitals to help develop the first community-based stroke program in the region.

UK Healthcare & College of Medicine
UK Healthcare is a fully integrated health system that includes the UK Colleges of Medicine, Health Sciences, Dentistry, Nursing, Pharmacy, and Public Health, allowing for ease of access and collaborations among peers – UK owns all of the hospitals within the UK HealthCare system. New COM leadership is in place with a new Dean, Robert DiPaola, MD and CMO, Philip Chang, MD. UK COM leadership has identified the neurosciences as 1 of 4 strategic pillars of growth, which supports further expansion and growth. In 2011, UK opened a $532 million, 1.2 million sq. ft. expansion pavilion in its Albert B. Chandler Hospital, which will help to serve a 25,000 square mile area with a catchment population of 8 million people. Additional UK Healthcare System facilities:

• Kentucky Children’s Hospital (KCH): KCH is the only facility in Central and Eastern Kentucky dedicated to the expert medical and surgical care of infants, children, and adolescents. KCH admits approximately 5,000 patients per year and houses the state’s only Level 1 Pediatric Trauma & Tertiary Referral Center and Level 4 NAEC Comprehensive Epilepsy Center. It has 66 NICU beds, currently expanding to an 80-single family bed unit, and 12 PICU beds.
• UK Albert B. Chandler Hospital: Two patient floors with a total of 128 beds (48 intensive care and 80 acute care beds in all private rooms) were the first to open: Floor 6 for neuroscience services and Floor 7 for trauma and acute care surgery patients. The hospital also houses the state’s only adult Level 1 Trauma & Tertiary Referral Center and Level 4 NAEC Comprehensive Epilepsy Center.
• Shriner’s Children’s Hospital: Located in Lexington, is relocating to the UK medical campus. Shriner’s Hospital will bring a wealth of Cerebral Palsy and Muscular Dystrophy patients, increasing opportunities for collaborative care, while approximately 75% of Shriner’s patient base has child neurology needs. Additionally, all of Shriner’s orthopedists will become UK faculty.
• Good Samaritan: 302 beds, more than 600 clinical and ancillary staff, and a medical staff of more than 600 physicians, 50,000sq ft medical office space, and the 2nd-largest orthopedic and joint replacement program in KY.
• Cardinal Hill Rehabilitation Hospital: After inpatient care, patients are referred to the Cardinal Hill Rehabilitation Hospital for neurological rehabilitation therapy as appropriate.

Research
For fiscal year 2016, UK COM reached $129.2 million in grants and contracts, including $66 million in NIH funding. Coupled with the UK Center for Clinical and Translational Science’s recent Clinical and Translational Science Award from the NIH, UK is part of a select national biomedical research consortium and is on the way to becoming a top 20 research institution.

Lexington, Kentucky
UK is located in Lexington, KY, and with a population of about 310,000 people, it is the second-largest city in the state and 61st in the country. Based in the heart of the Kentucky bluegrass region, Lexington is home to numerous horse and stock farms that all lend to its apt “Horse Capital of the World” nickname. While horseracing is a billion-dollar industry, Lexington has also emerged as one of the leading American cities in economic growth due to a concerted effort to diversify the area's economy toward more manufacturing and high-technology ventures. More than 100 major companies have headquarters or facilities located in Lexington, including Toyota, Xerox, Lexmark International, Lockheed-Martin and IBM, all Fortune 500 companies. Lexington ranks 6th on “America’s Best Value Cities,” and 10th and 13th in education and literacy, respectively.